Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Breast Cancer
85%
Ki-67
61%
Metformin
60%
AMP-activated Protein Kinase
53%
Ki-67 Expression
47%
Sequential Core
42%
Pictilisib
42%
Window of Opportunity Study
42%
ER Expression
42%
Therapeutic Potential
42%
PI3K Inhibitor
42%
Estrogen Receptor-positive Breast Cancer
42%
Tumor Immunity
42%
Anastrozole
42%
Gene Expression
42%
Core Needle Biopsy
42%
Programmed Death-ligand 1 (PD-L1)
42%
Endoplasmic Reticulum-associated Degradation
42%
New Therapeutics
42%
Mammalian Target of Rapamycin Pathway
25%
Immunohistochemistry
25%
Primary Breast Cancer
18%
Resection
17%
Drug Therapy
17%
Gene Analysis
17%
Ingenuity Pathway Analysis
17%
Pathway Genes
17%
Estrogen Therapy
17%
Cytotoxic T Lymphocytes
16%
Tumor
14%
Geometric Mean
14%
Luminal B
14%
Tumor Samples
13%
Lymphocyte Activity
10%
ER-associated Protein Degradation
10%
Tumor Cell Proliferation
9%
Ratio of Means
9%
Anticancer Effect
8%
Computer Search
8%
Pathway Dysregulation
8%
ER Pathway
8%
Consistency over Time
8%
Sequential Biopsy
8%
Affymetrix
8%
Therapeutic Avenues
8%
Diabetic Patients
8%
Non-treatment
8%
PubMed
8%
Drug Intervention
8%
ER +
8%
Medicine and Dentistry
Breast Cancer
100%
Pictilisib
42%
Gene Expression
42%
Anastrozole
42%
Estrogen Receptor Positive Breast Cancer
42%
Cyclic AMP Dependent Protein Kinase
42%
Hydroxymethylglutaryl Coenzyme A Reductase Kinase
42%
Biopsy Technique
42%
Biological Marker
34%
Neoplasm
27%
Mechanistic Target of Rapamycin
25%
Immunohistochemistry
25%
Messenger RNA
25%
Drug Therapy
17%
In Vitro
17%
Glycon
17%
Cell Proliferation
9%
Tumor Cell
9%
Primary Tumor
8%
Drug Efficacy
8%
Antiproliferative Activity
8%
Therapeutic Agent
8%
Hormone Receptor
8%
Microarray Analysis
8%
Malignant Neoplasm
8%
Diabetes Mellitus
8%
Adherence with Treatment
8%
